Iran's War Has Drained Half of America's Missile Arsenal — The Multi-Year Munitions Replenishment Cycle Powering LMT, RTX, and NOC Into an Earnings Breakout the Street Keeps Underestimating
Published April 28, 2026
Seven weeks of sustained operations against Iran have done something no budget hearing or white paper ever could: they've physically burned through roughly half of America's most critical missile inventories. The Pentagon now faces a replenishment challenge that defense analysts at CSIS are calling the largest forced restocking cycle since the Korean War — and Wall Street's earnings models for the companies that build those weapons are still catching up.
This isn't about order books anymore. Backlogs have been the headline story for months. What matters now is the hard industrial reality: depleted magazines must be refilled, production lines must be expanded, and the U.S. defense industrial base has no choice but to deliver. For investors in Lockheed Martin, RTX, and Northrop Grumman, that imperative translates into something far more tangible than a backlog number — it means accelerating revenue recognition, expanding margins on scaled production, and a multi-year earnings trajectory that consensus estimates still haven't fully absorbed.
📊 Related Stocks & ETFs at a Glance
| Ticker | Company / Fund | Sector | Iran Relevance | Signal |
|---|---|---|---|---|
| LMT | Lockheed Martin | Aerospace & Defense | PAC-3 interceptor, JASSM, LRASM, PrSM — all massively depleted in Iran ops | Bullish |
| RTX | RTX Corporation | Aerospace & Defense | Tomahawk, AMRAAM, SM-3/SM-6, Patriot system — record $271B backlog, munitions output up 40%+ YoY | Bullish |
| NOC | Northrop Grumman | Aerospace & Defense | Integrated battle management, munitions components, B-21 long-range strike | Bullish |
| GD | General Dynamics | Defense / Munitions | Ammunition and ordnance production, artillery shells, combat vehicle systems | Bullish |
| LHX | L3Harris Technologies | Defense Electronics | EW systems, ISR sensors, communications gear consumed/degraded in theater | Bullish |
| BA | Boeing | Aerospace & Defense | JDAM kits, Small Diameter Bomb, Harpoon — guided munitions supplier | Neutral |
| ITA | iShares U.S. Aerospace & Defense ETF | ETF | Broad defense sector exposure; top holdings LMT, RTX, NOC, GD | Bullish |
| DFEN | Direxion Daily Aerospace & Defense Bull 3X | Leveraged ETF | 3x leveraged bet on defense sector momentum; high volatility | Neutral |
| PPA | Invesco Aerospace & Defense ETF | ETF | Equal-weighted defense exposure; tilts toward mid-cap munitions suppliers | Bullish |
| XLE | Energy Select Sector SPDR | Energy ETF | Indirect beneficiary of Hormuz-driven oil price premium | Bullish |
The Arsenal Is Half Empty — and That Changes the Investment Math
Forget abstract geopolitical risk premiums for a moment. The investment case for U.S. defense primes right now is anchored in a single, brutally concrete fact: America's missile shelves are bare.
According to CNN reporting and CSIS analysis published in April 2026, the Iran campaign has consumed:
- ~50% of Patriot air defense interceptor missiles
- ~50% of THAAD interceptor inventory
- ~45% of Precision Strike Missiles (PrSM)
- ~30% of the Tomahawk cruise missile stockpile
- ~20%+ of JASSM (Joint Air-to-Surface Standoff Missile) reserves
- ~20% of SM-3 and SM-6 naval interceptors
Over 5,000 munitions were expended in the first 96 hours alone, according to the Foreign Policy Research Institute. The total cost of munitions consumed is measured in the tens of billions. And here's the critical point that separates this from a one-time spending event: Pentagon officials estimate it will take one to four years just to replenish these inventories to pre-war levels, and several additional years to expand them to where strategic planners believe they need to be — particularly given the ongoing China deterrence imperative.
LMT: The Interceptor and Standoff Missile Franchise
Lockheed Martin sits at the epicenter of the replenishment cycle. The company manufactures many of the weapons most aggressively consumed in the Iran campaign, and recent contract actions make the revenue trajectory unmistakable.
In January 2026, Lockheed signed a seven-year framework agreement to increase PAC-3 Patriot interceptor production capacity from 600 to 2,000 units annually — more than a threefold ramp. A $4.7 billion preliminary contract backstops the capacity expansion. Meanwhile, the Air Force allocated $780 million for development, procurement, and expanded production of Lockheed's LRASM (Long Range Anti-Ship Missile), one of the weapons whose inventories need urgent topping-up.
Q1 2026 results reflected the early innings of this ramp: $18.0 billion in revenue, with management guiding full-year sales between $77.5 billion and $80 billion — implying roughly 5% organic growth. But here's where the street may be behind: that guidance was set before the full scale of stockpile depletion became public in late April. As replenishment orders convert into production deliveries over the next 12-24 months, the revenue trajectory has meaningful upside optionality.
At a trailing P/E of roughly 26.6x and a forward multiple around 17.4x, Lockheed's valuation reflects a market that acknowledges growth but may still be discounting the durability of the munitions cycle. The median Wall Street price target stands at $665, with a high-end target of $770.
RTX: The Missile Production Machine Firing on All Cylinders
If Lockheed is the interceptor franchise, RTX is the full-spectrum missile factory — and Q1 2026 earnings told a story of a company hitting an operational inflection point.
Revenue came in at $22.1 billion, up 9% year-over-year (10% organic). Adjusted EPS of $1.78 crushed consensus expectations of $1.51-$1.52. The Raytheon defense segment posted 9% organic sales growth with operating margins expanding 150 basis points to 12.2% — driven by favorable program mix in land and air defense systems and a critical datapoint: munitions output up more than 40% year-over-year.
The company's backlog swelled to a record $271 billion, with a book-to-bill ratio of 1.56x — meaning for every dollar of revenue RTX recognized, $1.56 in new orders came in the door. Management signed five landmark framework agreements with the Pentagon covering Tomahawk, AMRAAM, and the Standard Missile family. Tomahawk production is being scaled toward 1,000 units per year.
RTX raised its full-year outlook: adjusted EPS now guided at $6.70-$6.90, with sales between $92.5 billion and $93.5 billion. Even at 33x trailing earnings, the market is paying for growth — and getting it. The margin expansion story is particularly compelling: as production lines scale, fixed costs get absorbed over more units, pushing margins higher in a virtuous cycle that has historically been the most powerful earnings driver in defense manufacturing.
NOC: The Stealth Beneficiary of the Replenishment Cycle
Northrop Grumman doesn't grab the same munitions-specific headlines as Lockheed or RTX, but the company is deeply embedded in the systems architecture that makes those munitions effective — and it's posting numbers that demand attention.
With a $95.7 billion record backlog, NOC has the largest order book relative to revenue of any prime contractor. Management guided for $43.5-$44 billion in 2026 sales, representing 4.5% revenue growth, though analysts at KeyBanc and Goldman Sachs expect the company to exceed that figure as large government awards materialize.
NOC's relevance to the replenishment cycle runs through several channels: the company is a critical supplier of solid rocket motors and munitions subsystems used in multiple missile programs; its IBCS (Integrated Battle Command System) is the nerve center connecting Patriot, THAAD, and other air defense assets that proved decisive in Iran operations; and the B-21 Raider long-range stealth bomber — whose strategic value was underscored by the Iran campaign — continues to ramp toward full-rate production.
The stock is up 29% in 2026, outpacing both LMT and the S&P 500. The market is beginning to price in the reality that Northrop isn't just a satellite and bomber company — it's a linchpin of the integrated air and missile defense architecture that the Iran war proved indispensable.
The Three Phases: Why This Isn't a One-Year Trade
What makes the current defense cycle different from previous geopolitical spikes is its structural depth. Investors who view this as a short-term war premium are missing the multi-phase nature of the demand signal:
Phase 1: Wartime Surge (Now Through Mid-2026)
Active operations drive immediate consumption. Existing production lines run at maximum capacity. Contracts are awarded on accelerated timelines. This phase is already reflected in current stock prices.
Phase 2: Arsenal Reconstitution (2026-2029)
This is the phase the market is still catching up to. With approximately half of critical missile inventories depleted, the Pentagon has no choice but to fund sustained multi-year procurement at rates significantly above peacetime norms. The $20.4 billion earmarked in FY2026 is just the opening salvo. FY2027's proposed $1.5 trillion defense budget embeds substantially more. Framework agreements already signed by LMT and RTX provide firm demand visibility extending three to seven years.
Phase 3: Expansion and Modernization (2028-2032+)
The Iran conflict exposed capability gaps — in air defense depth, standoff missile range, and autonomous systems — that the Pentagon will address through next-generation programs. This phase benefits companies across the defense industrial base but particularly favors those with R&D positioning in hypersonics, directed energy, and autonomous strike.
For investors, the critical implication is that the demand curve doesn't peak and decline after hostilities end. It transitions from consumption-driven to reconstitution-driven to modernization-driven — each phase generating years of contracted revenue.
What the Street Is Still Getting Wrong
Despite the rally in defense stocks, there are three systematic biases that may be causing consensus estimates to lag reality:
1. Linear Extrapolation of Production Ramps
Analyst models typically assume gradual production increases. But the framework agreements signed in early 2026 — like Lockheed's PAC-3 ramp from 600 to 2,000 units — represent step-function capacity expansions. As these lines come online through 2027, revenue could accelerate in a non-linear fashion that surprises consensus.
2. Underappreciation of Margin Leverage
RTX's Q1 showed it: 40% munitions output growth drove 150bps of margin expansion. The defense industry's cost structure — heavy on fixed manufacturing overhead, specialized tooling, and engineering amortization — means that volume increases flow disproportionately to the bottom line. Most sell-side models assume static or modestly improving margins; the production scaling underway could deliver meaningfully more.
3. Ignoring the Sustainment Tail
Every Patriot battery deployed, every Tomahawk fired from a destroyer, every THAAD system activated generates follow-on sustainment revenue — maintenance contracts, spare parts, software upgrades, training services. This recurring revenue stream typically equals 2-3x the original acquisition cost over a weapon system's lifecycle. The installed base of deployed and active systems has expanded dramatically during the Iran campaign, but sustainment revenue won't fully materialize for 12-18 months — placing it outside most analysts' near-term forecast windows.
Risks and Counterarguments
No investment thesis is without risk, and defense stocks carry specific vulnerabilities that investors should weigh:
- Ceasefire and De-escalation: A negotiated end to hostilities could trigger profit-taking. However, the replenishment imperative persists regardless of whether active combat continues — depleted stockpiles are a strategic vulnerability that the Pentagon cannot leave unaddressed.
- Budget Politics: The proposed $1.5 trillion FY2027 budget faces Congressional scrutiny. Deficit hawks may push back on the topline number. That said, munitions replenishment enjoys bipartisan support in a way that few defense line items do.
- Execution Risk: Tripling PAC-3 production requires workforce expansion, supply chain qualification, and facility buildouts that could encounter bottlenecks. Defense primes have historically struggled with production ramps — cost overruns and schedule delays are endemic to the sector.
- Valuation Stretch: RTX at 33x trailing earnings and LMT at 26x are not cheap by historical defense stock standards. If earnings growth disappoints or the cycle proves shorter than expected, multiple compression could offset fundamental improvements.
- China Deterrence Tradeoff: Some strategists argue that munitions consumed in Iran represent a net negative for U.S. strategic posture vis-à-vis China. If this narrative gains traction in policy circles, it could reshape procurement priorities in ways that benefit different weapons programs than those currently ramping.
How to Think About Positioning
Rather than chasing momentum, investors might consider how the three-phase demand cycle aligns with different portfolio objectives:
- RTX offers the most direct exposure to the munitions production ramp, with Q1 results demonstrating that operating leverage is already materializing. Its dual commercial-defense revenue base provides a natural hedge if defense spending disappoints.
- LMT is the pure-play on air and missile defense replenishment — the category most severely depleted. Its lower forward P/E (~17.4x) relative to peers suggests the market may be underweighting the PAC-3 ramp potential.
- NOC provides exposure to the longer-duration modernization phase (B-21, IBCS, space systems) while also participating in near-term munitions subsystem demand. Its 29% year-to-date gain suggests the market is beginning to recognize this positioning.
- ITA and PPA ETFs offer diversified defense exposure for investors who want sector participation without single-stock concentration risk.
The key question isn't whether these companies will benefit from the replenishment cycle — that's essentially a given, backed by signed contracts and Congressional appropriations. The real question is whether current valuations already discount the full multi-year earnings trajectory, or whether the market is still anchored to pre-war earnings models that underestimate both the duration and the margin profile of what's coming.
Based on the data — depleted stockpiles, signed framework agreements, expanding production margins, and a defense budget trajectory approaching $1.5 trillion — there's a credible case that consensus earnings estimates for all three primes will be revised upward over the next several quarters.
Sources consulted: CNN, CSIS, FPRI, Fortune, TIKR, Sci-Tech Today, 24/7 Wall St, CNBC, Motley Fool.
댓글
댓글 쓰기